Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01211652
First received: September 20, 2010
Last updated: January 28, 2013
Last verified: January 2013
  Purpose

The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • NSAID Treatment Compliance [ Time Frame: At the end of month 1 ] [ Designated as safety issue: No ]
  • Gastroprotective agent compliance (Girerd Questionnaire) [ Time Frame: At the end of month 1 ] [ Designated as safety issue: No ]

Enrollment: 8186
Study Start Date: October 2010
Study Completion Date: November 2010
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Community sample

Criteria

Inclusion Criteria:

  • French people > 65 years old, part of Kantar Health Access Santé panel
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01211652

  Show 3511 Study Locations
Sponsors and Collaborators
AstraZeneca
Investigators
Study Chair: Dr Jean-Francois Bretagne Service gastro-enterologie et hepatologie CHRU Pontchaillou 35033 RENNES cedex France
Study Chair: Pr Gerard Thiefin Service Hepato-Gastroenterologie CHU Reims 51092 REIMS cedex France
Principal Investigator: Mrs Genevieve BONNELYE KantarHealth - France138, avenue Marx Dormoy 92120 Montrouge cedex
  More Information

No publications provided

Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01211652     History of Changes
Other Study ID Numbers: NIS-PFR-DUM-2010/1
Study First Received: September 20, 2010
Last Updated: January 28, 2013
Health Authority: France: French Data Protection Authority

Keywords provided by AstraZeneca:
Compliance
France
Self-administered questionnaire to patients

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Therapeutic Uses
Pharmacologic Actions
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Antirheumatic Agents

ClinicalTrials.gov processed this record on April 22, 2014